Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis. FE [Internet]. 2022 Nov. 7 [cited 2026 Feb. 15];23(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1532